{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T10:08:19Z","timestamp":1747303699301,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL130153"],"award-info":[{"award-number":["HL130153"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK34818"],"award-info":[{"award-number":["DK34818"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00592-019-01422-6","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T05:02:57Z","timestamp":1568610177000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study"],"prefix":"10.1007","volume":"57","author":[{"given":"Jinghui","family":"Ju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin L.","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhobert W.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9303-3810","authenticated-orcid":false,"given":"Tina","family":"Costacou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"issue":"10","key":"1422_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","volume":"42","author":"MR Langlois","year":"1996","unstructured":"Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42(10):1589\u20131600","journal-title":"Clin Chem"},{"issue":"6","key":"1422_CR2","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.2337\/db08-0095","volume":"57","author":"T Costacou","year":"2008","unstructured":"Costacou T, Ferrell RE, Orchard TJ (2008) Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes. Diabetes 57(6):1702\u20131706","journal-title":"Diabetes"},{"issue":"11","key":"1422_CR3","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/dme.13127","volume":"33","author":"T Costacou","year":"2016","unstructured":"Costacou T, Evans RW, Orchard TJ (2016) Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in type 1 diabetes. Diabet Med 33(11):1524\u20131527","journal-title":"Diabet Med"},{"issue":"8","key":"1422_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.jdiacomp.2016.07.014","volume":"30","author":"TJ Orchard","year":"2016","unstructured":"Orchard TJ, Backlund JC, Costacou T et al (2016) Haptoglobin 2-2 genotype and the risk of coronary artery disease in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study (DCCT\/EDIC). J Diabetes Complic 30(8):1577\u20131584","journal-title":"J Diabetes Complic"},{"issue":"12","key":"1422_CR5","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.2337\/db09-0874","volume":"58","author":"T Costacou","year":"2009","unstructured":"Costacou T, Ferrell RE, Ellis D et al (2009) Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes 58(12):2904\u20132909","journal-title":"Diabetes"},{"issue":"9","key":"1422_CR6","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.2337\/db13-0256","volume":"62","author":"TJ Orchard","year":"2013","unstructured":"Orchard TJ, Sun W, Cleary PA et al (2013) Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study. Diabetes 62(9):3218\u20133223","journal-title":"Diabetes"},{"issue":"8","key":"1422_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/ars.2017.7444","volume":"29","author":"T Costacou","year":"2018","unstructured":"Costacou T, Orchard TJ, Moon CH et al (2018) Is magnetic resonance imaging detection of kidney iron deposition increased in haptoglobin 2-2 genotype carriers with type 1 diabetes? Antioxid Redox Signal 29(8):735\u2013741","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"1422_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jdiacomp.2015.11.011","volume":"30","author":"T Costacou","year":"2016","unstructured":"Costacou T, Orchard TJ (2016) The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes. J Diabetes Complications 30(2):221\u2013226","journal-title":"J Diabetes Complications"},{"issue":"1","key":"1422_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"Pop-Busui R, Boulton AJ, Feldman EL et al (2017) Diabetic neuropathy: a position statement by the american diabetes association. Diabetes Care 40(1):136\u2013154","journal-title":"Diabetes Care"},{"issue":"4","key":"1422_CR10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJ Boulton","year":"2005","unstructured":"Boulton AJ, Vinik AI, Arezzo JC et al (2005) Diabetic neuropathies: a statement by the american diabetes association. Diabetes Care 28(4):956\u2013962","journal-title":"Diabetes Care"},{"issue":"5","key":"1422_CR11","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI, Maser RE, Mitchell BD et al (2003) Diabetic autonomic neuropathy. Diabetes Care 26(5):1553\u20131579","journal-title":"Diabetes Care"},{"issue":"7","key":"1422_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/dmrr.1239","volume":"27","author":"V Spallone","year":"2011","unstructured":"Spallone V, Ziegler D, Freeman R et al (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27(7):639\u2013653","journal-title":"Diabetes Metab Res Rev"},{"key":"1422_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2018.0249","volume":"1","author":"MMB Christensen","year":"2018","unstructured":"Christensen MMB, Hommel EE, Jorgensen ME et al (2018) Prevalence of diabetic neuropathy in young adults with type 1 diabetes and the association with insulin pump therapy. Diabetes Technol Ther 1:1\u20132. \nhttps:\/\/doi.org\/10.1089\/dia.2018.0249","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"1422_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/pedi.12633","volume":"19","author":"M Jaiswal","year":"2018","unstructured":"Jaiswal M, Divers J, Urbina EM et al (2018) Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: the search for diabetes in youth cohort study. Pediatr Diabetes 19(4):680\u2013689","journal-title":"Pediatr Diabetes"},{"issue":"11","key":"1422_CR15","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/dme.13777","volume":"35","author":"CS Hansen","year":"2018","unstructured":"Hansen CS, Theilade S, Lajer M et al (2018) Cardiovascular autonomic neuropathy and bone metabolism in type 1 diabetes. Diabet Med 35(11):1596\u20131604","journal-title":"Diabet Med"},{"issue":"22","key":"1422_CR16","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1161\/CIRCULATIONAHA.108.837369","volume":"119","author":"R Pop-Busui","year":"2009","unstructured":"Pop-Busui R, Low PA, Waberski BH et al (2009) Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study (DCCT\/EDIC). Circulation 119(22):2886\u20132893","journal-title":"Circulation"},{"issue":"1","key":"1422_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1056-8727(00)00054-4","volume":"14","author":"P Stella","year":"2000","unstructured":"Stella P, Ellis D, Maser RE et al (2000) Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complic 14(1):1\u20136","journal-title":"J Diabetes Complic"},{"issue":"6","key":"1422_CR18","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2337\/diacare.26.6.1895","volume":"26","author":"RE Maser","year":"2003","unstructured":"Maser RE, Mitchell BD, Vinik AI et al (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26(6):1895\u20131901","journal-title":"Diabetes Care"},{"issue":"1","key":"1422_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2337\/dc16-1397","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"Pop-Busui R, Braffett BH, Zinman B et al (2017) Cardiovascular autonomic neuropathy and cardiovascular outcomes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study. Diabetes Care 40(1):94\u2013100","journal-title":"Diabetes Care"},{"issue":"3","key":"1422_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00149831-200506000-00006","volume":"12","author":"JH Christensen","year":"2005","unstructured":"Christensen JH, Krarup HB, Riahi S et al (2005) Heart rate variability is associated with haptoglobin phenotype in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 12(3):221\u2013225","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"1422_CR21","doi-asserted-by":"publisher","first-page":"650847","DOI":"10.1155\/2013\/650847","volume":"2013","author":"C Strandhave","year":"2013","unstructured":"Strandhave C, Svensson M, Krarup H et al (2013) Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease. Int J Nephrol 2013:650847","journal-title":"Int J Nephrol"},{"issue":"7","key":"1422_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2337\/diacare.13.7.741","volume":"13","author":"TJ Orchard","year":"1990","unstructured":"Orchard TJ, Dorman JS, Maser RE et al (1990) Factors associated with avoidance of severe complications after 25\u00a0yr of IDDM Pittsburgh epidemiology of diabetes complications study I. Diabetes Care 13(7):741\u2013747","journal-title":"Diabetes Care"},{"issue":"4","key":"1422_CR23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/clinchem\/23.4.666","volume":"23","author":"D Ellis","year":"1977","unstructured":"Ellis D, Buffone GJ (1977) New approach to evaluation of proteinuric states. Clin Chem 23(4):666\u2013670","journal-title":"Clin Chem"},{"issue":"9","key":"1422_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Int Med 150(9):604\u2013612","journal-title":"Ann Int Med"},{"issue":"9","key":"1422_CR25","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/clinchem\/48.9.1377","volume":"48","author":"W Koch","year":"2002","unstructured":"Koch W, Latz W, Eichinger M et al (2002) Genotyping of the common haptoglobin Hp 1\/2 polymorphism based on PCR. Clin Chem 48(9):1377\u20131382","journal-title":"Clin Chem"},{"issue":"18","key":"1422_CR26","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1089\/ars.2015.6355","volume":"23","author":"T Costacou","year":"2015","unstructured":"Costacou T, Evans RW, Orchard TJ (2015) Does the concentration of oxidative and inflammatory biomarkers differ by haptoglobin genotype in type 1 diabetes? Antioxid Redox Signal 23(18):1439\u20131444","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"1422_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jacc.2012.09.063","volume":"61","author":"LE Cahill","year":"2013","unstructured":"Cahill LE, Levy AP, Chiuve SE et al (2013) Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. J Am Coll Cardiol 61(7):728\u2013737","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1422_CR28","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0735-1097(02)02534-2","volume":"40","author":"AP Levy","year":"2002","unstructured":"Levy AP, Hochberg I, Jablonski K et al (2002) Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the strong heart study. J Am Coll Cardiol 40(11):1984\u20131990","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1422_CR29","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2337\/diacare.26.9.2628","volume":"26","author":"A Roguin","year":"2003","unstructured":"Roguin A, Koch W, Kastrati A et al (2003) Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes. Diabetes Care 26(9):2628\u20132631","journal-title":"Diabetes Care"},{"issue":"3","key":"1422_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jdiacomp.2016.11.002","volume":"31","author":"R Dimova","year":"2017","unstructured":"Dimova R, Tankova T, Guergueltcheva V et al (2017) Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance. J Diabetes Complic 31(3):537\u2013543","journal-title":"J Diabetes Complic"},{"issue":"3","key":"1422_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2337\/diabetes.50.3.630","volume":"50","author":"CH Foss","year":"2001","unstructured":"Foss CH, Vestbo E, Froland A et al (2001) Autonomic neuropathy in nondiabetic offspring of type 2 diabetic subjects is associated with urinary albumin excretion rate and 24-h ambulatory blood pressure: the Fredericia Study. Diabetes 50(3):630\u2013636","journal-title":"Diabetes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01422-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01422-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01422-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T23:32:15Z","timestamp":1600126335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01422-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01422-6","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the responsible institutional and national research committee on human experimentation and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}